An innovative clinical trial uses tumor biopsy information and unique statistical method to match four drugs to potential biomarkers that might guide treatment. Study leader Dr. Edward Kim of The University of Texas MD Anderson Cancer Center discusses BATTLE results.
BATTLE Promotes Personalized Approach for Lung Cancer
Previous post: Breathless…..My Moms Lung Cancer Journey
